Invention Grant
- Patent Title: Tiglien-3-one derivatives
-
Application No.: US16149977Application Date: 2018-10-02
-
Publication No.: US10543188B2Publication Date: 2020-01-28
- Inventor: Paul Warren Reddell , Victoria Anne Gordon
- Applicant: QBIOTICS PTY LTD
- Applicant Address: AU Taringa
- Assignee: QBIOTICS PTY LTD
- Current Assignee: QBIOTICS PTY LTD
- Current Assignee Address: AU Taringa
- Agency: Seed IP Law Group LLP
- Priority: AU2005907278 20051223
- Main IPC: A61K31/336
- IPC: A61K31/336 ; A01N43/20 ; A01N43/90 ; A01N45/00 ; C07D301/32 ; C07D303/14 ; C07D303/32 ; C07D493/04 ; A01N53/00 ; C07D303/44 ; C07D303/17 ; A61K9/00 ; A61K9/06 ; A61K47/10
Abstract:
The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
Public/Granted literature
- US20190099397A1 TIGLIEN-3-ONE DERIVATIVES Public/Granted day:2019-04-04
Information query
